Webinar Overview
With the rapid progression of T cell therapies, such as CAR-T and TCR-T, the need for an efficient media control strategy grows just as rapidly. While it can be difficult to find a balance for media replacement in culture systems that ensures T cell expansion and differentiation, advances in technologies including artificial intelligence (AI) are helping therapeutic developers develop successful methods for developing personalized medicines.
In this webinar, members of our Process Development team will share real-world case studies and their lessons learned while building out an optimized perfusion and media replacement strategy, and what it could mean for the future of your T cell therapy development.
View to learn:
- Why it’s crucial to strike the right balance for design optimized media control strategies for media replacement in culture systems
- A real-world case study that used these replacement strategies
- How design of experiment (DOE) and novel AI tools can optimize more advanced media control strategies for T cells and other cell types
Webinar Presenters
Alex Sargent, PhD
Director, Process Development, Cell Therapy CDMO Services
Charles River
Meredith Safford, PhD, MS
Process Development Scientist
Charles River